Could a common cholesterol drug help ease bipolar depression?
NCT ID NCT02481245
Summary
This study is testing whether adding a medication called bezafibrate to a person's current mood-stabilizing drugs can help reduce symptoms of depression in people with bipolar disorder. It will involve 30 adults over 8 weeks to check if the treatment is safe and shows signs of working. The goal is to gather early evidence to plan a larger, more definitive trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.